TRAPPC2B
gene geneOn this page
Also known as SEDLP1MIP-2A
Summary
TRAPPC2B (trafficking protein particle complex subunit 2B, HGNC:10710) is a protein-coding gene on chromosome 19q13.43, encoding Trafficking protein particle complex subunit 2B (P0DI82). Prevents transcriptional repression and induction of cell death by ENO1.
Enables transcription corepressor binding activity; transcription regulator inhibitor activity; and transmembrane transporter binding activity. Involved in positive regulation of gene expression and skeletal system development. Located in endoplasmic reticulum; nucleus; and perinuclear region of cytoplasm. Part of TRAPP complex.
Source: NCBI Gene 10597 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001355204
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10710 |
| Approved symbol | TRAPPC2B |
| Name | trafficking protein particle complex subunit 2B |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SEDLP1, MIP-2A |
| Ensembl gene | ENSG00000256060 |
| Ensembl biotype | protein_coding |
| OMIM | 620472 |
| Entrez | 10597 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000543226, ENST00000596755
RefSeq mRNA: 1 — MANE Select: NM_001355204
NM_001355204
CCDS: CCDS86812
Canonical transcript exons
ENST00000543226 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002267434 | 57363551 | 57363703 |
| ENSE00002277150 | 57364815 | 57365405 |
Expression profiles
Bgee: expression breadth ubiquitous, 148 present calls, max score 88.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.6705 / max 113.8635, expressed in 1801 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177769 | 18.6705 | 1801 |
Top tissues by expression
153 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 88.97 | gold quality |
| muscle of leg | UBERON:0001383 | 88.28 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.90 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.40 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 86.26 | gold quality |
| left testis | UBERON:0004533 | 85.94 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.90 | gold quality |
| left adrenal gland | UBERON:0001234 | 85.80 | gold quality |
| testis | UBERON:0000473 | 85.71 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.65 | gold quality |
| right testis | UBERON:0004534 | 85.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.34 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 85.32 | gold quality |
| islet of Langerhans | UBERON:0000006 | 85.22 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 85.14 | gold quality |
| adrenal gland | UBERON:0002369 | 85.13 | gold quality |
| heart left ventricle | UBERON:0002084 | 85.11 | gold quality |
| heart | UBERON:0000948 | 84.54 | gold quality |
| right atrium auricular region | UBERON:0006631 | 84.44 | gold quality |
| muscle tissue | UBERON:0002385 | 84.28 | gold quality |
| omental fat pad | UBERON:0010414 | 84.20 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.91 | gold quality |
| adipose tissue | UBERON:0001013 | 83.73 | gold quality |
| tibial artery | UBERON:0007610 | 83.45 | gold quality |
| popliteal artery | UBERON:0002250 | 83.43 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 83.42 | gold quality |
| placenta | UBERON:0001987 | 83.37 | gold quality |
| pituitary gland | UBERON:0000007 | 82.96 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 82.81 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-10 | yes | 44.32 |
| E-ANND-3 | yes | 6.10 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- MBP-1 interacting protein-2A (MIP-2A) preferentially expresses in certain tissues, including the pituitary gland, and negatively regulates the LHbeta gene transcription (MBP-1 interacting protein-2A) (PMID:12700240)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| rattus_norvegicus | Trappc2 | ENSRNOG00000042276 |
| drosophila_melanogaster | Trs20 | FBGN0266724 |
Paralogs (2): TRAPPC2L (ENSG00000167515), TRAPPC2 (ENSG00000196459)
Protein
Protein identifiers
Trafficking protein particle complex subunit 2B — P0DI82 (reviewed: P0DI82)
Alternative names: MBP-1-interacting protein 2A
All UniProt accessions (2): P0DI82, Q6IBE5
UniProt curated annotations — full annotation on UniProt →
Function. Prevents transcriptional repression and induction of cell death by ENO1. May play a role in vesicular transport from endoplasmic reticulum to Golgi.
Subunit / interactions. Can homodimerize. Part of the multisubunit TRAPP (transport protein particle) complex. Interacts with ENO1 and TRAPPC2L. Interacts with PITX1, SF1 and TRAPPC3.
Subcellular location. Nucleus. Cytoplasm. Perinuclear region. Endoplasmic reticulum-Golgi intermediate compartment.
Tissue specificity. Expressed in brain, heart, kidney, liver, lung, pancreas, placenta, skeletal muscle, fetal cartilage, fibroblasts, placenta and lymphocytes.
Miscellaneous. The gene encoding this protein appears to have arisen by retrotransposition of a cDNA from the X-linked locus TRAPPC2. The site of integration of this retrotransposed cDNA appears to lie within an intron of the ZNF547 gene, which provides a promoter and non-coding 5’ exon. TRAPPC2 and this protein are indistinguishable at protein level, and both proteins have been identified and functionally characterized.
Similarity. Belongs to the TRAPP small subunits family. Sedlin subfamily.
RefSeq proteins (1): NP_001342133* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006722 | Sedlin | Family |
| IPR011012 | Longin-like_dom_sf | Homologous_superfamily |
Pfam: PF04628
UniProt features (3 total): chain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DI82-F1 | 92.51 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 119
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 90 (showing top):
GOBP_VESICLE_LOCALIZATION, GOBP_VESICLE_ORGANIZATION, GOBP_VESICLE_TARGETING, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOBP_MEMBRANE_ORGANIZATION, GOBP_ORGANELLE_LOCALIZATION, HEIDENBLAD_AMPLICON_12P11_12_DN, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_OUTER_MEMBRANE, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT, GOCC_NUCLEAR_MEMBRANE, GOBP_GOLGI_VESICLE_TRANSPORT, GOMF_TRANSCRIPTION_COREGULATOR_BINDING
GO Biological Process (6): endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), vesicle coat assembly (GO:0006901), positive regulation of gene expression (GO:0010628), COPII vesicle coat assembly (GO:0048208), obsolete vesicle tethering (GO:0099022), vesicle-mediated transport (GO:0016192)
GO Molecular Function (3): transcription corepressor binding (GO:0001222), transcription regulator inhibitor activity (GO:0140416), protein binding (GO:0005515)
GO Cellular Component (10): nucleus (GO:0005634), nuclear outer membrane (GO:0005640), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), TRAPP complex (GO:0030008), perinuclear region of cytoplasm (GO:0048471), TRAPPII protein complex (GO:1990071), TRAPPIII protein complex (GO:1990072)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| intracellular membrane-bounded organelle | 3 |
| cellular anatomical structure | 3 |
| regulation of gene expression | 2 |
| Golgi apparatus | 2 |
| TRAPP complex | 2 |
| intercellular transport | 1 |
| intracellular transport | 1 |
| Golgi vesicle transport | 1 |
| vesicle budding from membrane | 1 |
| vesicle organization | 1 |
| gene expression | 1 |
| positive regulation of macromolecule biosynthetic process | 1 |
| vesicle coat assembly | 1 |
| protein-containing complex assembly | 1 |
| COPII-coated vesicle budding | 1 |
| transport | 1 |
| cellular process | 1 |
| transcription coregulator binding | 1 |
| transcription regulator activity | 1 |
| molecular function inhibitor activity | 1 |
| binding | 1 |
| nuclear membrane | 1 |
| organelle outer membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| vesicle tethering complex | 1 |
| intracellular protein-containing complex | 1 |
| endosome | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRAPPC1 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.530 |
| TRAPPC2B | ZBED1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| Trappc8 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.350 |
| TRAPPC11 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.350 |
| TRAPPC2 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.350 |
| TGOLN2 | BLTP3B | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (238): PITX1 (Affinity Capture-Western), NR5A1 (Affinity Capture-Western), TRAPPC2 (Affinity Capture-Western), TRAPPC2 (Two-hybrid), TRAPPC2 (Two-hybrid), TRAPPC2 (Two-hybrid), TRAPPC2 (Affinity Capture-Western), MBL2 (Affinity Capture-Western), TRAPPC2 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS)
ESM2 similar proteins: A7RJI7, B0G185, D3ZVF4, E2QV03, F1SRI0, O02173, O13732, O17901, O23685, O43041, O74891, P0DI81, P0DI82, P35181, P35604, P38334, P53600, P56377, P61923, P61924, P61966, P61967, Q03630, Q08CN0, Q0VD30, Q1JQ98, Q28HU2, Q28IG8, Q3T0F2, Q3ZBS3, Q4S4I5, Q54CU7, Q54RV6, Q54UU1, Q5R5F2, Q5RES6, Q5ZKP4, Q5ZLN2, Q74ZD2, Q7T102
Diamond homologs: A7RVK7, D3ZVF4, E2QV03, F1SRI0, O02173, P0DI81, P0DI82, P38334, Q08CN0, Q28IG8, Q3T0F2, Q54RV6, Q5RES6, Q5ZKP4, Q9CQP2, Q9USZ5, Q9VUZ1, B5FXJ6, Q54CU7, A6H7F7, B2RYU6, Q5M8X5, Q9JME7, Q9UL33, B5XGE7, Q5RBK9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TRAPPC2B | “form complex” | “TRAPP III complex, TRAPPC2B variant” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
260 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57364799:C:A | acceptor_gain | 1.0000 |
| 19:57363700:CGAGG:C | donor_loss | 0.9900 |
| 19:57363701:GAGGT:G | donor_loss | 0.9900 |
| 19:57363702:AGGT:A | donor_loss | 0.9900 |
| 19:57363703:GGTG:G | donor_loss | 0.9900 |
| 19:57363704:G:GA | donor_loss | 0.9900 |
| 19:57363705:T:A | donor_loss | 0.9900 |
| 19:57363701:GAG:G | donor_gain | 0.9800 |
| 19:57364800:G:A | acceptor_gain | 0.9800 |
| 19:57365024:TGGAC:T | donor_gain | 0.9800 |
| 19:57365308:A:T | donor_gain | 0.9800 |
| 19:57364813:A:AG | acceptor_gain | 0.9700 |
| 19:57364814:G:GG | acceptor_gain | 0.9700 |
| 19:57363611:G:GT | donor_gain | 0.9600 |
| 19:57363704:G:GG | donor_gain | 0.9600 |
| 19:57364807:C:A | acceptor_gain | 0.9600 |
| 19:57364814:GGA:G | acceptor_gain | 0.9600 |
| 19:57365040:GTG:G | donor_gain | 0.9600 |
| 19:57365307:G:GT | donor_gain | 0.9600 |
| 19:57364810:TGCAG:T | acceptor_loss | 0.9500 |
| 19:57364811:GCAGG:G | acceptor_loss | 0.9500 |
| 19:57364812:CAG:C | acceptor_loss | 0.9500 |
| 19:57364809:CTGCA:C | acceptor_loss | 0.9400 |
| 19:57363565:T:TA | donor_gain | 0.9300 |
| 19:57363566:A:AA | donor_gain | 0.9300 |
| 19:57365042:G:GA | donor_gain | 0.9300 |
| 19:57365107:G:GT | donor_gain | 0.9200 |
| 19:57365235:G:T | donor_gain | 0.9200 |
| 19:57365009:T:G | donor_gain | 0.9100 |
| 19:57365025:GGACA:G | donor_gain | 0.9100 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000872006 (19:57362631 A>T), RS1002242746 (19:57361838 T>A), RS1003415761 (19:57364215 A>G), RS1004253977 (19:57363788 C>G,T), RS1004598120 (19:57363228 G>A,C), RS1004823774 (19:57363372 T>G), RS1006088961 (19:57362066 A>G), RS1006680846 (19:57361670 T>C), RS1007857454 (19:57364769 C>A,T), RS1008346997 (19:57365099 T>C), RS1008726714 (19:57363411 T>C,G), RS1009364431 (19:57364453 T>C), RS1009743086 (19:57364240 G>A), RS1010225948 (19:57362576 T>C), RS1010404280 (19:57362181 G>A)
Disease associations
OMIM: gene MIM:620472 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Selenium | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Zinc | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.